GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (XPAR:ALBPS) » Definitions » Institutional Ownership

Biophytis (XPAR:ALBPS) Institutional Ownership : 0.45% (As of Jun. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Biophytis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biophytis's institutional ownership is 0.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biophytis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biophytis's Float Percentage Of Total Shares Outstanding is 99.82%.

Biophytis Institutional Ownership Historical Data

The historical data trend for Biophytis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biophytis Institutional Ownership Chart

Biophytis Historical Data

The historical data trend for Biophytis can be seen below:

2022-08-31 2022-09-30 2023-02-28 2023-03-31 2023-05-31 2023-06-30 2023-07-31 2023-08-31 2023-11-30 2023-12-31
Institutional Ownership 0.34 0.34 0.23 0.10 5.09 1.99 0.45 0.19 2.69 0.45

Biophytis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Biophytis (XPAR:ALBPS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biophytis SA (XPAR:ALBPS) » Definitions » Institutional Ownership
Comparable Companies
XPAR:ALVET XPAR:ALMDP XPAR:ALQGC XPAR:ALTME XPAR:ALINT XPAR:ALPAT XPAR:ALTHX XPAR:ALNFL XPAR:ALNEV XPAR:ALPHA OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
BPTSY:USA 0D1W:UK 6XB3:Germany
Address
BC 9, Batiment A 4eme etage, 4 pace Jussieu, Sorbonne University, Paris, FRA, 75005
Website
https://www.biophytis.com
Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Its drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and DMD.

Biophytis (XPAR:ALBPS) Headlines

No Headlines